CIK 0001635077 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aclarion, Inc.
Sign in to watch- Ticker
- ACON
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324725
- Phone
- 833 275 2266
- Business address
- 8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
- Former names
- Nocimed, Inc.
Securities
- ACON Common Stock Nasdaq
- ACONW Warrant Nasdaq
- DEFA14A Proxy Proxy Materials
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Agreement ended
- 8-K Event Shareholder vote results
- S-1/A Offering Registration Statement
Page 4 of 14 · 276 filings